183 related articles for article (PubMed ID: 33632702)
1. The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
McCormack M; Gaffney D; Tan D; Bennet K; Chavez-Blanco A; Plante M
Int J Gynecol Cancer; 2021 May; 31(5):775-778. PubMed ID: 33632702
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
3. The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup.
Gaffney DK; Suneja G; Ryu SY; McCormick M; Plante M; Mileshkin L; Small W; Bacon M; Stuart G; Kitchener H
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):506-8. PubMed ID: 26068483
[No Abstract] [Full Text] [Related]
4. The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.
Ward ZJ; Grover S; Scott AM; Woo S; Salama DH; Jones EC; El-Diasty T; Pieters BR; Trimble EL; Vargas HA; Hricak H; Atun R
Lancet Oncol; 2020 Aug; 21(8):1089-1098. PubMed ID: 32758463
[TBL] [Abstract][Full Text] [Related]
5. Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review.
Williams-Brennan L; Gastaldo D; Cole DC; Paszat L
Arch Gynecol Obstet; 2012 Dec; 286(6):1487-505. PubMed ID: 23011733
[TBL] [Abstract][Full Text] [Related]
6. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
[TBL] [Abstract][Full Text] [Related]
7. EuroMed Cancer Network contributions to eliminating cervical cancer in low- and middle-income Mediterranean countries.
Jaramillo L; Camussi E; Dotti M; Ferrante G; Segnan N; Castagno R; Ullrich A; Giordano L;
East Mediterr Health J; 2023 Nov; 26(11):894-902. PubMed ID: 38279885
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
Saxena U; Sauvaget C; Sankaranarayanan R
Asian Pac J Cancer Prev; 2012; 13(4):1699-703. PubMed ID: 22799391
[TBL] [Abstract][Full Text] [Related]
9. Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey.
Akinyemiju TF
PLoS One; 2012; 7(11):e48834. PubMed ID: 23155413
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer worldwide.
Vu M; Yu J; Awolude OA; Chuang L
Curr Probl Cancer; 2018 Sep; 42(5):457-465. PubMed ID: 30064936
[TBL] [Abstract][Full Text] [Related]
11. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
12. Biomedical Application of Identified Biomarkers Gene Expression Based Early Diagnosis and Detection in Cervical Cancer with Modified Probabilistic Neural Network.
Ramesh K; Agarwal P; Ahuja V; Mir BA; Yuriy S; Altuwairiqi M; Nuagah SJ
Contrast Media Mol Imaging; 2022; 2022():4946154. PubMed ID: 36134120
[TBL] [Abstract][Full Text] [Related]
13. The development of priority cervical cancer trials: a Gynecologic Cancer InterGroup report.
Kitchener HC; Hoskins W; Small W; Thomas GM; Trimble EL;
Int J Gynecol Cancer; 2010 Aug; 20(6):1092-100. PubMed ID: 20683424
[TBL] [Abstract][Full Text] [Related]
14. Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.
Omura GA;
Semin Oncol; 2008 Oct; 35(5):507-21. PubMed ID: 18929149
[TBL] [Abstract][Full Text] [Related]
15. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
16. Women's cancers in developing countries: from research to an integrated health systems approach.
Reeler A; Qiao Y; Dare L; Li J; Zhang AL; Saba J
Asian Pac J Cancer Prev; 2009; 10(3):519-26. PubMed ID: 19640202
[TBL] [Abstract][Full Text] [Related]
17. Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Médecins Sans Frontières', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
Chilinda G; Massamba L; Meja S; Ngo C; Dupre PF
Int J Gynecol Cancer; 2021 Dec; 31(12):1606-1607. PubMed ID: 34083379
[No Abstract] [Full Text] [Related]
18. Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.
Demment MM; Peters K; Dykens JA; Dozier A; Nawaz H; McIntosh S; Smith JS; Sy A; Irwin T; Fogg TT; Khaliq M; Blumenfeld R; Massoudi M; De Ver Dye T
PLoS One; 2015; 10(9):e0134618. PubMed ID: 26325181
[TBL] [Abstract][Full Text] [Related]
19. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.
Denny L; de Sanjose S; Mutebi M; Anderson BO; Kim J; Jeronimo J; Herrero R; Yeates K; Ginsburg O; Sankaranarayanan R
Lancet; 2017 Feb; 389(10071):861-870. PubMed ID: 27814963
[TBL] [Abstract][Full Text] [Related]
20. SOGC–GOC–SCC Joint Policy Statement. No. 255, March 2011. Cervical cancer prevention in low-resource settings.
Elit L; Jimenez W; McAlpine J; Ghatage P; Miller D; Plante M; ; ;
J Obstet Gynaecol Can; 2011 Mar; 33(3):272-9. PubMed ID: 21453569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
